New Variant Posing Threat, as Global Vaccine Drive Falters - The New York Times

New Variant Posing Threat, as Global Vaccine Drive Falters - The New York Times The Pfizer-BioNTech vaccine offered 88 percent protection against the variant first sampled in India, only a slight drop from the 93 percent protection given against the variant from Britain, Public Health England said. The AstraZeneca-Oxford vaccine was 60 percent effective against the variant from India, compared to 66 percent effective against the one first seen in Britain. Those are not great odds.